We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current VRNA market cap is 3.41B. The company's latest EPS is USD and P/E is N/A.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| GBP (£) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 5.62M |
| Operating Income | -38.33M | -54.08M | -26.61M | -71.23M | -107.99M |
| Net Income | -14.69M | -14.13M | -25.79M | -70.84M | -42.96M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| GBP (£) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 40M | 458k | 0 |
| Operating Income | -40.74M | -74.28M | -73.31M | -75.75M | -67.57M |
| Net Income | -31.94M | -65.11M | -55.57M | -68.7M | -54.37M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| GBP (£) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 292.47M | 308.12M | 289.91M | 434.12M | 381.82M |
| Total Liabilities | 28.94M | 58.84M | 64.92M | 265.85M | 251.33M |
| Total Equity | 263.53M | 249.28M | 224.99M | 168.27M | 130.49M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| GBP (£) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 45.14M | 204.21M | 186.59M | 259.47M | 308.12M |
| Total Liabilities | 11.27M | 19.35M | 38.58M | 29M | 58.84M |
| Total Equity | 33.87M | 184.85M | 148.01M | 230.47M | 249.28M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| GBP (£) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -39.82M | -50.22M | -13.61M | -30.71M | -93.37M |
| Investing | N/A | N/A | -16k | -45k | -45k |
| Financing | 68.86M | 92.87M | -3.12M | 163.71M | 156.62M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| GBP (£) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -33.82M | -45.08M | -33.25M | -59.86M | -50.22M |
| Investing | 37.8M | 9.71M | -12k | -29k | N/A |
| Financing | -426k | 192.34M | -6.12M | 140.82M | 92.87M |
| Market Cap | 3.41B |
| Price to Earnings Ratio | N/A |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0 |
| Price to Book Ratio | 0 |
| Dividend Yield | - |
| Shares Outstanding | 81.83M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 2.54 (5.91%) |
| Company Name | Verona Pharma Plc |
| Address |
one central square london CF10 1FS |
| Website | https://www.veronapharma.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
